355 related articles for article (PubMed ID: 4735136)
1. Premenstrual symptoms.
Br Med J; 1973 Mar; 1(5855):689-90. PubMed ID: 4735136
[TBL] [Abstract][Full Text] [Related]
2. Sex hormones and headache.
Silberstein SD
Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
[TBL] [Abstract][Full Text] [Related]
3. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
Cianci A; De Leo V
Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
[TBL] [Abstract][Full Text] [Related]
4. Adolescent menstrual irregularity.
Mansfield MJ; Emans SJ
J Reprod Med; 1984 Jun; 29(6):399-410. PubMed ID: 6379175
[TBL] [Abstract][Full Text] [Related]
5. The use of prostaglandin inhibitors for the premenstrual syndrome.
Budoff PW
J Reprod Med; 1983 Jul; 28(7):469-78. PubMed ID: 6350580
[TBL] [Abstract][Full Text] [Related]
6. Tension and depression in women--the place of hormone therapy.
Taylor RW
Practitioner; 1980 Sep; 224(1347):908-11. PubMed ID: 7192399
[TBL] [Abstract][Full Text] [Related]
7. Luteal phase treatment of premenstrual dysphoric disorder improves symptoms that continue into the postmenstrual phase.
Yonkers KA; Pearlstein T; Fayyad R; Gillespie JA
J Affect Disord; 2005 Apr; 85(3):317-21. PubMed ID: 15780701
[TBL] [Abstract][Full Text] [Related]
8. Premenstrual syndrome.
Dickerson LM; Mazyck PJ; Hunter MH
Am Fam Physician; 2003 Apr; 67(8):1743-52. PubMed ID: 12725453
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a unique oral contraceptive (Yasmin) in the management of premenstrual dysphoric disorder.
Freeman EW
Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():27-34; discussion 42-3. PubMed ID: 12659404
[TBL] [Abstract][Full Text] [Related]
10. [Triella: a French multicenter double blind clinical study].
Castaigne JP
Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):445-53. PubMed ID: 12280213
[TBL] [Abstract][Full Text] [Related]
11. Nutritional factors in the etiology of the premenstrual tension syndromes.
Abraham GE
J Reprod Med; 1983 Jul; 28(7):446-64. PubMed ID: 6684167
[TBL] [Abstract][Full Text] [Related]
12. Use of norethindrone .35 mg in disorders of the menstrual cycle.
Ferrari AN; Berge I; Rosito CL; Russowsky M; Barbisan AB; Roeche T
J Bras Ginecol; 1970 May; 69(5):299-306. PubMed ID: 12259292
[TBL] [Abstract][Full Text] [Related]
13. Premenstrual syndrome and premenstrual dysphoric disorder: quality of life and burden of illness.
Rapkin AJ; Winer SA
Expert Rev Pharmacoecon Outcomes Res; 2009 Apr; 9(2):157-70. PubMed ID: 19402804
[TBL] [Abstract][Full Text] [Related]
14. Premenstrual syndrome.
Levine EM; O'Connor T; Barton JJ
Compr Ther; 1985 May; 11(5):12-5. PubMed ID: 4040000
[TBL] [Abstract][Full Text] [Related]
15. Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.
Borges LE; Andrade RP; Aldrighi JM; Guazelli C; Yazlle ME; Isaia CF; Petracco A; Peixoto FC; Camargos AF
Contraception; 2006 Dec; 74(6):446-50. PubMed ID: 17157100
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric complications of progesterone and oral contraceptives.
Glick ID; Bennett SE
J Clin Psychopharmacol; 1981 Nov; 1(6):350-67. PubMed ID: 7037875
[TBL] [Abstract][Full Text] [Related]
17. Severe premenstrual tension: delineation of the syndrome.
Haskett RF; Steiner M; Osmun JN; Carroll BJ
Biol Psychiatry; 1980 Feb; 15(1):121-39. PubMed ID: 7188863
[TBL] [Abstract][Full Text] [Related]
18. Drospirenone in the treatment of severe premenstrual cerebral edema in a woman with antiphospholipid syndrome, lateral sinus thrombosis, situs inversus and epileptic seizures.
Vujović S; Zidverc J; Stojanović M; Penezić Z; Ivović M; Dukić V; Drezgić M
Gynecol Endocrinol; 2005 Nov; 21(5):243-7. PubMed ID: 16373242
[TBL] [Abstract][Full Text] [Related]
19. Effect of an oral contraceptive containing drospirenone and ethinylestradiol on general well-being and fluid-related symptoms.
Apter D; Borsos A; Baumgärtner W; Melis GB; Vexiau-Robert D; Colligs-Hakert A; Palmer M; Kelly S
Eur J Contracept Reprod Health Care; 2003 Mar; 8(1):37-51. PubMed ID: 12725674
[TBL] [Abstract][Full Text] [Related]
20. Communicating with women about menstrual cycle symptoms.
Ballagh SA; Heyl A
J Reprod Med; 2008 Nov; 53(11):837-46. PubMed ID: 19097516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
